NASDAQ:RNA

Avidity Biosciences Stock Insider Trading

etoro logo Buy RNA
*Your capital is at risk
$12.24
-0.1000 (-0.81%)
At Close: Aug 10, 2026

Avidity Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -75.71. In total, the insiders bought 930.67K and sold 596.87K RNA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-75.71
Buy 930.67K shares
Sell 596.87K shares
47% Buy Activity
Negligible or No Correlation
Sell Signal Medium Confidence
Aug 10, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -75.71.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Dec 17, 2025
Buy
Common Stock
A-Award
Flanagan W. Michael
Chief Scientific Officer
Officer 27 500
Value: $1.98M
Dec 17, 2025
Buy
Common Stock
A-Award
Calderaro Charles Iii
Chief Technical Officer
Officer 23 250
Value: $1.67M
Dec 17, 2025
Sell
Common Stock
F-InKind
Calderaro Charles Iii
Chief Technical Officer
Officer 9 726
Value: $699.0K
Dec 17, 2025
Sell
Common Stock
F-InKind
Flanagan W. Michael
Chief Scientific Officer
Officer 13 695
Value: $984.3K
Dec 17, 2025
Sell
Common Stock
F-InKind
Mosbrooker Eric
Chief Commercial Officer
Officer 36 564
Value: $2.63M
Dec 17, 2025
Sell
Common Stock
F-InKind
Mosbrooker Eric
Chief Commercial Officer
Officer 11 426
Value: $821.2K
Dec 17, 2025
Sell
Common Stock
F-InKind
Boyce Sarah
President And CEO
CEO / President 15 742
Value: $1.13M
Dec 17, 2025
Buy
Common Stock
A-Award
Moriarty John B
Chief Legal Officer
Officer 56 000
Value: $4.02M
Dec 17, 2025
Buy
Common Stock
A-Award
Gallagher Kathleen P.
Chief Program Officer
Officer 72 000
Value: $5.17M
Dec 17, 2025
Sell
Common Stock
F-InKind
Gallagher Kathleen P.
Chief Program Officer
Officer 33 336
Value: $2.40M
Dec 17, 2025
Buy
Common Stock
A-Award
Mccarthy Teresa
Chief Human Resources Officer
Officer 39 000
Value: $2.80M
Oct 22, 2025
Sell
Common Stock
S-Sale
Hughes Steven George
Chief Medical Officer
Officer 2 209
Value: $105.0K
Oct 22, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Hughes Steven George
Chief Medical Officer
Officer 2 209
Value: $22.4K
Oct 22, 2025
Buy
Common Stock
M-Exempt
Hughes Steven George
Chief Medical Officer
Officer 2 209
Value: $22.4K
Oct 15, 2025
Buy
Common Stock
M-Exempt
Mccarthy Teresa
Chief Human Resources Officer
Officer 20 000
Value: $446.8K
Oct 15, 2025
Sell
Common Stock
S-Sale
Mccarthy Teresa
Chief Human Resources Officer
Officer 20 000
Value: $1.00M
Oct 15, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Mccarthy Teresa
Chief Human Resources Officer
Officer 20 000
Value: $446.8K
Oct 03, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Mosbrooker Eric
Chief Commercial Officer
Officer 6 562
Value: $59.4K
Oct 03, 2025
Buy
Common Stock
M-Exempt
Mosbrooker Eric
Chief Commercial Officer
Officer 6 562
Value: $59.4K
Oct 03, 2025
Sell
Common Stock
S-Sale
Mosbrooker Eric
Chief Commercial Officer
Officer 6 562
Value: $297.8K
Oct 03, 2025
Sell
Common Stock
S-Sale
Mosbrooker Eric
Chief Commercial Officer
Officer 6 562
Value: $297.8K
Oct 03, 2025
Buy
Common Stock
M-Exempt
Mosbrooker Eric
Chief Commercial Officer
Officer 6 562
Value: $59.4K
Oct 03, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Mosbrooker Eric
Chief Commercial Officer
Officer 6 562
Value: $59.4K
Sep 22, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Hughes Steven George
Chief Medical Officer
Officer 2 208
Value: $22.4K
Sep 22, 2025
Buy
Common Stock
M-Exempt
Hughes Steven George
Chief Medical Officer
Officer 2 208
Value: $22.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT AVIDITY BIOSCIENCES LLC
Avidity Biosciences
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to tr...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE